Armistice Capital »

Melco Crown Entertainment shares owned by Armistice Capital

Quarter-by-quarter ownership of Melco Crown Entertainment (MLCO) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Melco Crown Entertainment

Tip: Access up to 7 years of quarterly data

All positions including Melco Crown Entertainment held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Melco Crown Entertainment by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 200k 7.21
2023-06-30 $2.6M 215k 12.21

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Melco Crown Entertainment

ARGA Investment Management
Eminence Capital
Coronation Fund Managers
Citadel Advisors
Johnston Asset Management Corp.
Goldman Sachs Group
Nuveen Asset Management
BlackRock
Morgan Stanley
UBS Group
Owl Creek Asset Management
Balyasny Asset Management
Invenomic Capital Management
New York State Common Retirement Fund
Torq Capital Management

View all funds holding Melco Crown Entertainment